Foreword
Preface
About the Author
Chapter 1: Introduction
Chapter 2: Pharmaceutical Quality Control and Assurance
Chapter 3: Processes
Chapter 4: Bioprocessing
Chapter 5: Crystallization
Chapter 6: Particle Size: Reduction and Classification
Chapter 7: Mixing
Chapter 8: Solid Dosage Forms
Chapter 9: Solid-Liquid Extraction
Chapter 10: Filtration
Chapter 11: Evaporation and Distillation
Chapter 12: Air Conditioning and Humidification
Chapter 13: Drying
Chapter 14: Sterilization
Chapter 15: Fluid Flow
Chapter 16: Heat Transfer
Chapter 17: Mass Transfer
Chapter 18: Powders
Chapter 19: Conclusion
Appendix
Index
Biography
Anthony J. Hickey is Distinguished Fellow Emeritus at RTI International, Research Triangle Park, NC; Professor Emeritus of Pharmacoengineering and Molecular Pharmaceutics of the Eshelman School of Pharmacy; and Adjunct Professor of Biomedical Engineering in the School of Medicine at the University of North Carolina at Chapel Hill. He is a Fellow of the American Association for the Advancement of Science, the American Association of Pharmaceutical Scientists, the Academy of Pharmaceutical Sciences of Great Britain, the Royal Society of Biology, the Royal Society of Medicine, and the National Academy of Inventors. He received the Research Achievement Award of the Particulate Presentations and Design Division of the Powder Technology Society of Japan, the David W Grant Award in Physical Pharmacy of the American Association of Pharmaceutical Scientists, Thomas T Mercer Joint Prize for Excellence in Inhaled Medicines and Pharmaceutical Aerosols of the American Association for Aerosol Research and the International Society for Aerosols in Medicine, and the Ralph Shangraw Memorial Award for Excipient and Excipient Technology of the International Pharmaceutical Excipient Consortium Foundation. He is founder (and formerly President and CEO) of Cirrus Pharmaceuticals, Inc.; founder (formerly CSO) of Oriel Therapeutics, Inc,; CEO of Astartein, LLC.; Member of the Board of First Flight Venture Center, Inspiring Pty Ltd., and KAER Biotherapeutics; Chair of the USP Joint Sub-Committee on Nanotechnology; and Member of the USP Pharmaceutical Dosage Forms Expert Committee (DFEC) and Inhalation Sub-Committee of the DFEC of the United States Pharmacopeia. He consults on multidisciplinary research programs in the field of pulmonary drug and vaccine delivery for the treatment and prevention of a variety of diseases and serves on numerous editorial and scientific advisory boards.
